We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
-4.14%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$9.42M
(+4%)
Cap. Flow
+$20.6M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
52.48%
Holding
84
New
6
Increased
12
Reduced
28
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$13.6M |
| 2 |
Intel
INTC
|
+$4.99M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.96M |
| 4 |
SLB Ltd
SLB
|
+$3.45M |
| 5 |
Cars.com
CARS
|
+$1.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.59M |
| 2 |
GG
Goldcorp Inc
GG
|
+$1.27M |
| 3 |
SPDR Gold Trust
GLD
|
+$1.26M |
| 4 |
Colgate-Palmolive
CL
|
+$836K |
| 5 |
Corning
GLW
|
+$678K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Energy | 16.26% |
| 3 | Technology | 13.56% |
| 4 | Consumer Staples | 9.11% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$8.6B
| $26.6M | 10.8% |
413,372
-3,613
| -0.9% | -$255K |
|
|
2
SPDR Gold Trust
GLD
$131B
| $21.4M | 8.7% |
160,704
-10,185
| -6% | -$1.26M |
|
|
3
Intel
INTC
$455B
| $14.5M | 5.91% |
303,593
+100,715
| +50% | +$4.99M |
|
|
4
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $12.8M | 5.19% |
+7,678
| New | +$13.6M |
|
|
5
SLB Ltd
SLB
$73.6B
| $12.7M | 5.17% |
316,336
+85,670
| +37% | +$3.45M |
|
6
AT&T
T
$159B
| $10.1M | 4.09% |
397,313
-12,668
| -3% | -$304K |
|
|
PXD
7
DELISTED
Pioneer Natural Resource Co.
PXD
| $8.75M | 3.56% |
56,881
-1,034
| -2% | -$159K |
|
8
Patterson-UTI
PTEN
$3.98B
| $7.82M | 3.18% |
679,245
+1,200
| +0.2% | +$15.4K |
|
9
Kraft Heinz
KHC
$30.7B
| $7.34M | 2.98% |
236,370
+33,690
| +17% | +$1.06M |
|
10
Merck
MRK
$322B
| $7.17M | 2.91% |
89,006
-3,851
| -4% | -$295K |
|
11
ProShares Short High Yield
SJB
$51.8M
| $7.01M | 2.85% |
326,125
-12,180
| -4% | -$265K |
|
12
Procter & Gamble
PG
$336B
| $6.84M | 2.78% |
62,354
-2,715
| -4% | -$289K |
|
13
Nutrien
NTR
$33.2B
| $6.23M | 2.53% |
115,238
-11,600
| -9% | -$606K |
|
14
NXP Semiconductors
NXPI
$57.8B
| $5.6M | 2.28% |
57,230
+480
| +0.8% | +$46.5K |
|
15
Campbell Soup
CPB
$6.55B
| $5.56M | 2.26% |
138,710
-6,280
| -4% | -$247K |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $5.1M | 2.07% |
+93,280
| New | +$4.96M |
|
|
17
Cars.com
CARS
$662M
| $4.99M | 2.03% |
253,220
+75,890
| +43% | +$1.62M |
|
18
Targa Resources
TRGP
$58B
| $4.62M | 1.88% |
117,665
+680
| +0.6% | +$27K |
|
19
APA Corp
APA
$13.2B
| $4.55M | 1.85% |
157,060
+21,935
| +16% | +$682K |
|
20
OraSure Technologies
OSUR
$279M
| $3.8M | 1.54% |
409,624
-42,725
| -9% | -$393K |
|
|
21
Corning
GLW
$119B
| $3.42M | 1.39% |
102,775
-21,125
| -17% | -$678K |
|
22
Clean Harbors
CLH
$16.5B
| $3.18M | 1.29% |
44,745
-6,440
| -13% | -$448K |
|
23
Alphabet (Google) Class A
GOOGL
$4.36T
| $2.68M | 1.09% |
49,480
-1,320
| -3% | -$76.4K |
|
24
Vanguard Total International Stock ETF
VXUS
$155B
| $2.56M | 1.04% |
48,457
| – | – |
|
25
Fortuna Silver Mines
FSM
$2.55B
| $2.51M | 1.02% |
879,380
-24,100
| -3% | -$69.6K |
|
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Sicart Associates held 84 positions worth $246M, up 4% from $237M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sicart Associates deployed $20.6M of net new capital in Q2 2019, opening 6 new positions and adding to 12 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 7,678 shares worth $12.8M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.26M trimmed.
- Sicart Associates's largest Q2 2019 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 7,678 shares worth $12.8M.
- Sicart Associates added most to Intel in Q2 2019, an estimated $4.99M increase.
- Sicart Associates's biggest Q2 2019 reduction was SPDR Gold Trust, cutting an estimated $1.26M.
- Sicart Associates fully exited Microsoft in Q2 2019, selling an estimated $1.59M.
- Sicart Associates's ten largest holdings make up 52% of its $246M portfolio in Q2 2019.
- Sicart Associates opened 6 new positions and closed 6 in Q2 2019.
- Sicart Associates's portfolio value rose 4% quarter-over-quarter to $246M.
Based on Sicart Associates's 13F filing for Q2 2019, filed 23 Jul 2019.